--- title: "NVNO Q2'26 Earnings: revenue estimate is 0 USD" type: "News" locale: "en" url: "https://longbridge.com/en/news/293603437.md" description: "NVNO (enVVeno Medical Corporation) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (4.69) USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported—————Revenue Estimate———500.00 K—Revenue Surprise-100.00%EPS Reported(11.55)(5.88) EPS Estimate(9.80)(10.50)(9.80)(8.40)(4.69) EPS Surprise-17.86%+30.00%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc." datetime: "2026-07-23T11:01:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293603437.md) - [en](https://longbridge.com/en/news/293603437.md) - [zh-HK](https://longbridge.com/zh-HK/news/293603437.md) generator: "portal-rs" --- # NVNO Q2'26 Earnings: revenue estimate is 0 USD NVNO (enVVeno Medical Corporation) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC). For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (4.69) USD. Learn more details at . **Revenue & EPS values are provided in USD** | | Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | | -------------------- | ------- | ------- | ------ | -------- | ------ | | **Revenue Reported** | — | — | — | — | — | | **Revenue Estimate** | — | — | — | 500.00 K | — | | **Revenue Surprise** | | | | -100.00% | | | **EPS Reported** | (11.55) | | | (5.88) | | | **EPS Estimate** | (9.80) | (10.50) | (9.80) | (8.40) | (4.69) | | **EPS Surprise** | -17.86% | | | +30.00% | | **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. ### Related Stocks - [NVNO.US](https://longbridge.com/en/quote/NVNO.US.md) ## Related News & Research - [enVVeno Medical wins FDA IDE approval for enVVe pivotal trial in deep venous insufficiency](https://longbridge.com/en/news/297191037.md) - [Igua Sergipe board signs off Q2 2026 financial results](https://longbridge.com/en/news/297932404.md) - [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md) - [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md) - [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**